Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.80 |
| ▸ | CA9 | Q16790 | 5/20 | 0.80 |
| ▸ | CA1 | P00915 | 1/20 | 0.80 |
| ▸ | CA3 | P07451 | 1/20 | 0.80 |
| ▸ | CA4 | P22748 | 1/20 | 0.80 |
| ▸ | CA6 | P23280 | 1/20 | 0.80 |
| ▸ | CA5A | P35218 | 1/20 | 0.80 |
| ▸ | CA7 | P43166 | 1/20 | 0.80 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.80 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.80 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | DAO | P14920 | 2/20 | 0.44 |
| ▸ | F11 | P03951 | 1/20 | 0.44 |
| ▸ | DDO | Q99489 | 1/20 | 0.44 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.44 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL31503134 | 1.00 | CA12 (0.80) | CA12CA9CA1CA3CA4 | |
| SCHEMBL28110424 | 0.92 | CA12 (0.74) | CA12CA9CA1CA3CA4 | |
| SCHEMBL5437282 | 0.89 | CA12 (1.00) | CA12CA9CA1CA3CA4 | |
| SCHEMBL29351086 | 0.89 | CA12 (1.00) | CA12CA9CA1CA3CA4 | |
| SCHEMBL30958273 | 0.89 | CA12 (1.00) | CA12CA9CA1CA3CA4 | |
| SCHEMBL8621 | 0.89 | CA12 (1.00) | CA12CA9CA1CA3CA4 | |
| Trifluoromethanesulfonic Acid SCHEMBL2480378 | 0.88 | CA12 (0.67) | CA12CA9CA1CA3CA4 | |
| Methyl Alcohol SCHEMBL10568722 | 0.88 | CA12 (0.87) | CA12CA9CA1CA3CA4 | |
| Water SCHEMBL10661261 | 0.87 | CA12 (0.95) | CA12CA9CA1CA3CA4 | |
| Hydrochloric Acid SCHEMBL1824447 | 0.87 | CA12 (0.95) | CA12CA9CA1CA3CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1664 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3615053-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TRYPTOPHAN AND PHYLLOKININ DERIVATIVE FOR USE IN TREATING PSYCHIATRIC AND PSYCHOLOGICAL CONDITIONS | Temple Otorongo LLC (US) | 2020-03-04 | — | — | EP | claimed |
| CN-110191876-A | FORMULATIONS FOR ADMINISTRATION OF EFLORNITHINE | 奥巴斯治疗股份有限公司 | 2019-08-30 | — | — | CN | claimed |
| EP-3523274-A1 | FORMULATIONS FOR ADMINISTRATION OF EFLORNITHINE | Orbus Therapeutics, Inc. (US) | 2019-08-14 | — | — | EP | claimed |
| WO-2018200381-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TRYPTOPHAN AND PHYLLOKININ DERIVATIVE FOR USE IN TREATING PSYCHIATRIC AND PSYCHOLOGICAL CONDITIONS | TEMPLE OTORONGO LLC (US) | 2018-11-01 | — | — | WO | claimed |
| WO-2018148206-A1 | TREATMENT OF DIABETES AND ASSOCIATED METABOLIC CONDITIONS WITH EPIGENETIC MODULATORS | TEMPLE OTORONGO LLC (US) | 2018-08-16 | — | — | WO | claimed |
| WO-2018067401-A1 | FORMULATIONS FOR ADMINISTRATION OF EFLORNITHINE | Orbus Therapeutics, Inc. (US) | 2018-04-12 | — | — | WO | claimed |
| EP-2797569-B1 | AQUEOUS OXIDIZING COMPOSITION | KAO GERMANY GMBH (DE) | 2017-10-25 | — | — | EP | claimed |
| EP-3205334-A1 | METHOD AND COMPOSITION FOR TREATING OCULAR HYPERTENSION AND GLAUCOMA | Santen Pharmaceutical Co., Ltd. (JP) | 2017-08-16 | — | — | EP | claimed |
| EP-2772249-B1 | Method and composition for treating ocular hypertension and glaucoma | SANTEN PHARMACEUTICAL CO LTD (JP) | 2017-05-03 | — | — | EP | claimed |
| US-9573909-B2 | 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides | FMC CORPORATION (US) | 2017-02-21 | — | — | US | claimed |
| US-20020177624-A1 | Acetate-lactate buffering vaginal gel and for method of making same and treating bacterial vaginosis | BLANSETT PHARMACAL COMPANY, INC. | 2002-11-28 | — | — | US | claimed |
| EP-1133985-A1 | PRESSURE-SENSITIVE ADHESIVE GEL COMPOSITION FOR IONTOPHORESIS AND APPARATUS THEREFOR | HISAMITSU PHARMACEUTICAL CO. INC. (JP) | 2001-09-19 | — | — | EP | claimed |
| WO-2001060337-A1 | COMPOSITIONS FOR TOPICAL DELIVERY OF A PHARMACEUTICALLY ACTIVE AGENT HAVING REDUCED OXIDATION | THE PROCTER & GAMBLE COMPANY (US) | 2001-08-23 | — | — | WO | claimed |
| EP-0126684-B1 | DRUG DELIVERY SYSTEM UTILIZING THERMOSETTING GELS | MERCK & CO. INC. (US) | 1991-08-28 | — | — | EP | claimed |
| EP-0148242-A4 | METHOD AND APPARATUS FOR TREATING AILMENTS. | KRAUSER ROBERT S | 1987-06-03 | — | — | EP | claimed |
| EP-0148242-A1 | METHOD AND APPARATUS FOR TREATING AILMENTS. | KRAUSER ROBERT S | 1985-07-17 | — | — | EP | claimed |
| US-4523589-A | INHALATION THROUGH NASAL PASSAGES | VIRAL RESPONSE SYSTEMS, INC., A DE. CORP. | 1985-06-18 | — | — | US | claimed |
| WO-1985000112-A1 | METHOD AND APPARATUS FOR TREATING AILMENTS | KRAUSER ROBERT S | 1985-01-17 | — | — | WO | claimed |
| EP-0126684-A2 | Drug delivery system utilizing thermosetting gels | MERCK & CO. INC. (US) | 1984-11-28 | — | — | EP | claimed |
| US-4478822-A | Drug delivery system utilizing thermosetting gels | MERCK & CO., INC. (US) | 1984-10-23 | — | — | US | claimed |